Bayer appoints Joyce Lee to Lead North American Animal Health Business

News provided by

Mar 21, 2016, 02:03 ET

SHAWNEE, Kan., March 21, 2016 /PRNewswire/ -- Bayer today announced the appointment of Joyce Lee as President of Bayer's North American Animal Health business, headquartered in Shawnee, Kansas. Lee will report to Dirk Ehle, the Animal Health company's global President, a position he has held since 2012.

"Lee is a highly respected and knowledgeable leader in the animal health industry and I'm thrilled to have someone with such vast knowledge of the industry leading the North American team," said Ehle. "Having spent over a decade in the animal health industry in a range of roles with increasing management responsibility, Joyce will be a critical asset as we look to build customer relationships and continue to seek innovative solutions for animal health."

Previously, Lee was the Executive Vice President and Area President of Canada and Latin America at Zoetis, a role she held since 2013. She has over 20 years of experience in Marketing & Commercial Operations in emerging and developed markets within the Life Sciences industry at global, regional and country level. Lee has held a number of senior leadership positions at companies including Pharmacia, Pfizer and Zoetis, focusing on strategic planning, sales management, commercial operations and leading a global business.

Lee earned her Masters of Business Administration from Jacksonville University and completed her undergraduate study at Baylor University. She and her husband will be relocating to the Kansas City area from New Jersey. Her first official day with Bayer will be April 1, 2016.

Bayer: Science For A Better Life
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2014, the Group employed around 119,000 people and had sales of EUR 42.2 billion. Capital expenditures amounted to EUR 2.5 billion, R&D expenses to EUR 3.6 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independence company named Convestro on October 6, 2015. For more information, go to www.bayer.com.

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Logo - http://photos.prnewswire.com/prnh/20140312/NY79226LOGO

SOURCE Bayer